BioMed Research International

Volume 2014 (2014), Article ID 248656, 9 pages

http://dx.doi.org/10.1155/2014/248656

Research Article

Antibacterial and Antioxidant Activities of Derriobtusone A Isolated from Lonchocarpus obtusus

Mayron Alves Vasconcelos,1,2,3 Francisco Vassiliepe Sousa Arruda,³ Daniel Barroso de Alencar,⁴ Silvana Saker-Sampaio,⁴ Maria Rose Jane Ribeiro Albuquerque,⁵ Hélcio Silva dos Santos,⁵ Paulo Nogueira Bandeira,⁵ Otília Deusdênia Loiola Pessoa,⁶ Benildo Sousa Cavada,¹ Mariana Henriques,² Maria Olivia Pereira,² and Edson Holanda Teixeira³

¹Laboratory of Biologically Active Molecules, Biochemistry and Molecular Biology Department, Federal University of Ceará, 60.440-970 Fortaleza, CE, Brazil

²Institute for Biotechnology and Bioengineering (IBB), Centre of Biological Engineering, University of Minho, 4710-057 Braga, Portugal

³Integrated Laboratory of Biomolecules (LIBS), Department of Pathology and Legal Medicine, Federal University of Ceará, 62.042-280 Fortaleza, CE, Brazil

⁴Marine Natural Products Laboratory, Department of Fishing Engineering, Federal University of Ceará, 60.440-970 Fortaleza, CE, Brazil

⁵Centre of Exact Sciences and Technology, Acaraú Valley State University, 62.040-370 Sobral, CE, Brazil

⁶Department of Organic and Inorganic Chemistry, Federal University of Ceará, 60.021-940 Fortaleza, CE, Brazil

Received 27 February 2014; Accepted 9 May 2014; Published 1 June 2014

Academic Editor: Sebastien Fiorucci

Copyright © 2014 Mayron Alves Vasconcelos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

This study evaluated the effect of derriobtusone A, a flavonoid isolated from Lonchocarpus obtusus, on two important pathogenic bacteria, Staphylococcus aureus and Escherichia coli, as well as its antioxidant activity and toxicity. Planktonic growth assays were performed, and the inhibition of biofilm formation was evaluated. In addition, antioxidant activity was assessed by DPPH radical scavenging assay, ferrous ion chelating assay, ferric-reducing antioxidant power assay, and β-carotene bleaching assay. Toxicity was evaluated by the brine shrimp lethality test. Results showed that derriobtusone A completely inhibited the planktonic growth of S. aureus at 250 and 500 μg/mL; however, it did not have the same activity on E. coli. Derriobtusone A reduced the biomass and colony-forming unit (cfu) of S. aureus biofilm at concentrations of 250 and 500 μg/mL. In various concentrations, it reduced the biofilm biomass of E. coli, and, in all concentrations, it weakly reduced the cfu. Derriobtusone A showed highly efficient antioxidant ability in scavenging DPPH radical and inhibiting β-carotene oxidation. The compound showed no lethality to Artemia sp. nauplii. In conclusion, derriobtusone A may be an effective molecule against S. aureus and its biofilm, as well as a potential antioxidant compound with no toxicity.

1. Introduction

Biofilm is a complex agglomeration of microbes adhering to a solid surface and to one another, all encased in a scaffold of self-produced extracellular polymeric substances [1]. By the ability to produce such extracellular polymeric substances, bacteria present in microbial biofilm show a reduced growth pattern, with up- and downregulation of specific genes [2]. Physiological and phenotypical adaptations that result in antimicrobial tolerance have been attributed to biofilm formation [3]. Biofilm formation is directly related to various infectious diseases through colonization on medical devices [4, 5]. Several pathogenic bacteria are capable of forming biofilms; among them are Staphylococcus aureus and Escherichia coli [6, 7]. However, plants are rich in a wide variety of molecules with antimicrobial properties, such as secondary metabolites and proteins [8]. In fact, several studies have reported on the antimicrobial and antibiofilm activities of plant compounds as alternatives to antibiotic therapy [9–12].

Furthermore, the antioxidant activities on reactive oxygen species (ROS) and other free radicals have been attributed to plant molecules, mostly phenolic compounds [13]. A common denominator of environmental stress is the production and accumulation of ROS, such as superoxide anions (), hydrogen peroxide (), hydroxyl radicals (), and singlet oxygen () [13]. ROS accumulation leads to oxidative stress that can damage cellular components, such as DNA, lipids, proteins, and sugars [14, 15]. Moreover, ROS are associated with toxic effects and pathologies such as cancers, cardiovascular and neurological diseases, and infections [16]. In this context, the use of antioxidant compounds with the aim of increasing the degradation of ROS and thereby reducing ROS-associated diseases has been studied [17].

Some studies have reported that plants of the genus Lonchocarpus are able to produce compounds, such as alkaloids and triterpenoids, derived from benzoic acids and flavonoids [18–22]. Lonchocarpus is a genus of the family Leguminosae, subfamily Papilionoideae, and it is prevalent in tropical and subtropical regions, including Brazil [20, 22].

Flavonoids are phenolic compounds consisting of two benzene rings linked through a heterocyclic pyrimidine ring [23]. Moreover, flavonoids have been reported to possess many useful properties, such as anti-inflammatory, antiallergic, antitumor, antioxidant, and antimicrobial activities [24–29]. Aurone constitutes a subclass of flavonoids consisting of a benzofuranone ring linked through a carbon-carbon double bond to a phenyl moiety [30], and auronol is an aurone derivative in which the benzylidene unsaturation has undergone hydration [31]. These compounds comprise a very small group of flavonoids [31, 32].

Derriobtusone A is a methylated auronol with a fairly rare occurrence (2-Benzoyl-3-methoxybenzo[1,2-b:3,4-b′]difuran.) [19]. This compound was the first auronol found in nature and was initially extracted and isolated from the roots of Lonchocarpus obtusus by Nascimento and colleagues [19, 20]. Furthermore, derriobtusone A also was isolated from the roots of Lonchocarpus montanus, being among the most abundant compounds found in this species [19]. Over thirty years have passed since derriobtusone A was identified. However, only few studies have evaluated the biological activities of this compound. Therefore, the present study aims to evaluate the antibacterial effects of derriobtusone A on Staphylococcus aureus and Escherichia coli. The antioxidant effects and toxicity of this compound were also demonstrated.

2. Material and Methods

2.1. Plant Material

The roots of Lonchocarpus obtusus were collected from Meruoca City (Ceará State, Brazil). Plant authentication was performed by Professor Afrânio Gomes Fernandes, and a voucher specimen (number 39550) was deposited at the Herbário Prisco Bezerra (EAC) of the Departamento de Biologia, Universidade Federal do Ceará.

2.2. Derriobtusone A Isolation

Derriobtusone A was isolated as described previously by Cavalcante et al. [22]. Dried root bark (720 g) and wood (750 g) of Lonchocarpus obtusus were powdered and then extracted at room temperature with n-hexane (). During the distillation process, a yellowish precipitate was filtrated, and the compound derriobtusone A was purified by crystallization in acetone (Figure 1).

Figure 1: Chemical structure of derriobtusone A extracted from the root bark of Lonchocarpus obtusus.

2.3. Microorganisms

In the present study, the microorganisms used in the experiments were Staphylococcus aureus JKD 6008, a Gram-positive bacterium, and Escherichia coli ATCC 47076, a Gram-negative bacterium.

2.4. Culture Conditions

The bacteria were grown in Trypticase Soy Agar medium (TSA; Liofilchem, Italy) and incubated at 37°C for 24 h. After growth on the solid medium, an isolated colony was removed and inoculated into 10 mL of Trypticase Soy Broth (TSB; Liofilchem, Italy) and incubated for 18 h at 37°C under constant agitation of 120 rpm. Prior to use, the cell concentration of each inoculum was adjusted to 2 × 10⁶ cells/mL using a spectrophotometer (620 nm) and calibration curves previously determined for each bacterium.

2.5. Planktonic Growth Assay

The effect of derriobtusone A on planktonic growth of S. aureus and E. coli was determined by the broth microdilution method. Briefly, in 96-well polystyrene plates, derriobtusone A was diluted in TSB (with 4 % of dimethyl sulfoxide [DMSO]) in concentrations of 3.9 to 250 μg/mL. The plates were incubated at 37°C during 24 h under constant agitation at 120 rpm. Optical density of the contents of each well was recorded at 640 nm (OD₆₄₀) using an automated Elisa reader (Synergy TM HT multidetection microtiter reader), as a measure of microbial growth. Minimum inhibitory concentration (MIC) was established as the lowest concentration of compound able to inhibit the visible growth of microorganism after overnight incubation.

2.6. Biofilm Assays

The methodology used to grow biofilms was based on the microtiter plate test developed by Stepanovi et al. [33] with some modifications. Sterile 96-well polypropylene plates were prepared using a procedure similar to that used for the planktonic growth assays with the same initial concentration of cells and derriobtusone A. All plates were incubated on a horizontal shaker (120 rpm) at 37°C during 24 h for biofilm development. After biofilm growth in the presence or absence of derriobtusone A, the content of each well was removed, and the biofilms were washed twice with 200 μL/well of sterilized water to remove weakly adherent cells.

2.6.1. Biomass Quantification

Quantification of biofilm biomass was determined by crystal violet staining. For fixation of biofilms, 200 μL of 99% methanol (Romil, UK) was added to each well, and, after 15 min, the methanol was removed and the plates were dried at room temperature. Then, 200 μL of crystal violet stain (Merck, Germany) was added to each well. After 5 min, the excess of crystal violet was removed, and the plates were washed in water. Finally, 200 μL of acetic acid (33%, v/v) (Pronalab, Portugal) was added to all wells to dissolve the crystal violet staining, and the absorbance was measured at 570 nm (OD₅₇₀).

2.6.2. Quantification of Colony-Forming Units

After biofilm formation, 200 μL of sterile water was added to each well, and the plate was placed in an ultrasonic bath (Sonicor SC-52; Sonicor Instruments, Copiague, NY, USA, operating at 50 kHz during 6 min). Serial decimal dilutions from the obtained suspension were plated on TSA. The plates were then incubated for 24 h at 37°C, and the total number of colony-forming units (cfu) per unit area (log₁₀cfu/cm²) of microtiter plate well was enumerated.

2.7. Antioxidant Assays

2.7.1. DPPH (1,1-Difenil-2-picrilidrazil) Radical Scavenging Assay

The DPPH scavenging activity of derriobtusone A at concentrations from 7.8 to 500 μg/mL was measured according to the method described by Duan et al. [34]. The absorbance of sample, blank sample, and control was measured at 517 nm, after 30 min incubation in the dark at room temperature, using a Biochrom Asys UVM 340 microplate reader (Cambridge, UK). The sample consisted of a mixture of 1 mL DPPH methanolic solution (0.16 mM) with 1 mL of derriobtusone A. The blank sample consisted of 2 mL of derriobtusone A, while the control contained 2 mL DPPH methanolic solution (0.16 mM) only. Ascorbic acid was used as positive control. The percentage of DPPH scavenging activity was calculated with the following equation:

2.7.2. Ferrous Ion Chelating (FIC) Assay

The ferrous ion chelating (FIC) power of derriobtusone A was determined with the method described by Wang et al. [35]. Distilled water, 2 mM ferrous chloride (FeCl₂), and 5 mM ferrozine were added to the compound at concentrations from 7.8 to 500 μg/mL. The blank sample and the control were prepared with distilled water instead of ferrozine and the compound, respectively. The sample, the blank sample, and the control were incubated at room temperature for 10 min, and the optical density was measured at 562 nm using a microplate reader (Biochrom Asys UVM 340). Ethylenediamine tetraacetic acid (EDTA) was used as positive control. FIC activity was calculated with the following equation:

2.7.3. Ferric-Reducing Antioxidant Power (FRAP)

Ferric-reducing antioxidant power (FRAP) of derriobtusone A was determined using the method described by Ganesan et al. [36]. Initially, 0.2 M phosphate buffer (pH 6.6) and 1% potassium ferricyanide were added to the compound at different concentrations (7.8 to 500 μg/mL). The samples were then incubated at 50°C for 20 min. After cooling at room temperature, 10% trichloroacetic acid was added. An aliquot was mixed with distilled water and 0.1% ferric chloride. Ten minutes later, the optical density was measured at 700 nm using a microplate reader (Biochrom Asys UVM 340). Butylated hydroxyanisole (BHA) was used as positive control. Greater absorbance indicated greater FRAP.

2.7.4. β-Carotene Bleaching (BCB) Assay

The coupled oxidation of β-carotene and linoleic acid was determined with the method described by Chew et al. [37]. Tween 40 was added to β-carotene (100 μg/mL in chloroform) and linoleic acid. Following evaporation of the chloroform in a rotating evaporator, oxygen-saturated ultrapure water (Milli-Q) was added, and the mixture was shaken until forming an emulsion. Thus, the final sample was a mixture of emulsion and compound, while the control consisted of emulsion only. The optical density was measured at 470 nm using a microplate reader (Biochrom Asys UVM 340), followed by another 3 hours of incubation at 50°C. BHA was used as positive control. The antioxidant activity was calculated with the following equation:

2.8. Artemia Lethality Test

Artemia sp. cysts were hatched in sterile artificial seawater at 28°C under constant light and strong aeration. The cysts were incubated in a polyethylene cylindroconical tube with 1 g of cysts per liter of artificial seawater. After a period of 48 h, the nauplii were collected and used for bioassays.

Derriobtusone A was dissolved in artificial seawater (with 4% DMSO) at a concentration of 1 mg/mL. The assay was performed boarding 24-well Linbro plates in which each well contained 10 Artemia sp. nauplii in a final volume of 2 mL. The compound solution was added to the wells at final concentrations of 7.8 to 500 μg/mL. The experiments were performed in triplicate, and negative control wells contained 2 mL of artificial seawater (with 4% DMSO) with 10 Artemia sp. nauplii. After 24 and 48 h, the number of dead nauplii in each well was counted.

2.9. Statistical Analysis

Statistical analyses were performed by GraphPad Prism version 5.0 from Microsoft Windows. The data from all the antimicrobial and biofilm assays were compared using one-way analysis of variance (ANOVA), with Bonferroni post hoc test. was considered to be statistically significant.

For antioxidant assays, the percentage values obtained for DPPH, FIC, and BCB with each concentration were converted into absolute values, submitted to angular transformation, and compared with Student’s t-test for independent data. FRAP values, as obtained for each concentration, were also analyzed with Student’s t-test for independent data. was considered to be statistically significant.

3. Results

3.1. Effect of Derriobtusone A on Planktonic Growth

The results showed that derriobtusone A inhibited the planktonic growth of Staphylococcus aureus at concentrations of 250 (MIC) and 500 μg/mL. When bacteria were treated with concentrations ranging from 15.5 to 125 μg/mL, only a weakly inhibition was seen (Figure 2(a)). On the other hand, derriobtusone A at concentrations of 250 and 500 μg/mL showed a weakly inhibition on Escherichia coli planktonic growth (Figure 2(b)).

(a)

(b)

Figure 2: Effect of derriobtusone A on planktonic growth of (a) S. aureus and (b) E. coli. compared to control.

3.2. Effect of Derriobtusone A on Biofilm

Figure 3(a) presents the results of biofilm biomass of Staphylococcus aureus and Escherichia coli after 24 h of contact with derriobtusone A. At concentrations of 250 and 500 μg/mL, data showed that the compound was able to abruptly reduce the biomass of Staphylococcus aureus and significantly reduce the biomass of Escherichia coli at concentrations ranging from 15.6 to 250 μg/mL.

(a)

(b)

Figure 3: Effect of derriobtusone A on biofilm of S. aureus and E. coli. (a) Biofilm biomass and (b) enumeration of cfu. compared to control.

Figure 3(b) presents mean values and standard deviations of log₁₀cfu/cm² for both Staphylococcus aureus and Escherichia coli. Similar to the biomass results, derriobtusone A at concentrations of 250 and 500 μg/mL reduced the cfu in S. aureus biofilm by approximately 2.0 log₁₀. Interestingly, derriobtusone A was able to reduce the cfu in Escherichia coli biofilm between 0.2 and 0.4 log₁₀ in all concentrations.

3.3. Antioxidant Activity of Derriobtusone A

Derriobtusone A antioxidant activity was evaluated by four different methods: DPPH radical scavenging, FIC, FRAP, and BCB.

In the DPPH assay, the compound was able to scavenge DPPH radical in all concentrations, performing this activity between 50 and 60%. Ascorbic acid (positive control) showed significant difference compared to derriobtusone A in all concentrations, performing this activity between 70 and 97% (Figure 4(a)).

(a)

(b)

(c)

(d)

Figure 4: Antioxidant activity of derriobtusone A. (a) Scavenging activity of DPPH (%), (b) chelating ability of ferrous ion (%), (c) reducing power of ferric ions, and (d) β-carotene bleaching assay (%). compared to positive control.

Using the FIC assay, derriobtusone A showed chelating ability of ferrous ion by approximately 8, 10, 14, 17, 19, 22, and 34 % in concentrations of 7.8 to 500 μg/mL, respectively, while the positive control (EDTA) showed significantly greater activity than the compound. In the higher concentrations, EDTA showed approximately 100% activity (Figure 4(b)).

Derriobtusone A was evaluated by ferric reducing/antioxidant power assay to determine its ability to reduce Fe³⁺ to Fe²⁺. In this assay, the results showed that optical density increased weakly with increasing concentrations of the compound. The variation of optical density for derriobtusone A ranged from 0.168 to 0.222, while BHA, the positive control, showed an abrupt increase of 0.226 to 1.283 in optical density (Figure 4(c)).

The ability of derriobtusone A to inhibit β-carotene oxidation was also evaluated. The compound showed a high antioxidant activity, ranging from 68.7 to 96.5%. Moreover, the antioxidant activity was similar to positive control in the higher concentrations (Figure 4(d)).

3.4. Toxicity of Derriobtusone A on Artemia sp

The toxicity of the derriobtusone A on Artemia sp. nauplii was evaluated after 24 and 48 hours of exposure. Interestingly, the compound showed no lethality to Artemia sp. nauplii at any of the concentrations tested (data not shown).

4. Discussion

Staphylococcus aureus and Escherichia coli are two microorganisms generally associated with human infections, and they exhibit considerable antimicrobial resistance based on the ability to form biofilms [6, 7, 38, 39]. This study evaluated the effect of derriobtusone A, a flavonoid isolated from Lonchocarpus obtusus, on planktonic growth and biofilm formation of Staphylococcus aureus and Escherichia coli.

The planktonic growth assay showed that Staphylococcus aureus was susceptible to the presence of derriobtusone A in that the molecule totally inhibited bacterial growth at 250 μg/mL. On the other hand, Escherichia coli showed more resistance against the compound. This study corroborated the findings of Magalhães et al. [40] who showed that derriobtusone A isolated from Lonchocarpus montanus was activeagainst Staphylococcus aureus, but not against Escherichia coli in a bioautography assay. Other studies have also shown the antibacterial activity of flavonoids in different concentrations [28, 29]. Panduratin A, a chalcone isolated from Kaempferia pandurata, showed antibacterial action against clinical Staphylococcus strains in concentrations between 0.063 and 2 μg/mL [41]. Sepicanin A, a flavanone isolated from Artocarpus sepicanus, inhibited the bacterial growth of Staphylococcus aureus at 1.2 μg/mL [42]. Furthermore, the molecule 4′-methoxyflavanone showed action against Staphylococcus aureus in concentrations up to 1000 μg/mL [43].

The differences in antibacterial activity of flavonoids at various concentrations have also been investigated. For example, according to Basile and coworkers [44], apigenin, a flavanone isolated from Castanea sativa, inhibited the growth of Staphylococcus aureus at concentrations up to 128 μg/mL, but, in another study, Sato and coworkers [45] showed that this same flavonoid isolated from Scutellaria barbata inhibited the growth of strains of Staphylococcus aureus at concentrations between 3.9 and 15.6 μg/mL. These discrepancies could be attributed to the different techniques employed to evaluate the antimicrobial action of flavonoids, different solvents used to dissolve the molecules, or the provenance of flavonoid [29].

Flavonoids are diverse compounds of plants which play important roles in growth and defense against microorganisms and pests [46]. In fact, the antibacterial activity of flavonoids is linked to their structure. Li and colleagues [47] showed that the linking of N-heterocyclic ring to the A ring of chrysin makes this molecule 16- to 32-fold more active against Escherichia coli and Staphylococcus aureus than its parent compound. Several antibacterial mechanisms of action have been assigned to these compounds. According to Cushnie and Lamb [29], the possible mechanisms of action of the flavonoids are as follows: damage in cytoplasmic membrane, causing pores in membrane or reduction in fluidity; inhibition of nucleic acid synthesis by the inhibition of the enzyme topoisomerase; inhibition of cellular metabolism, resulting from inhibition of the enzyme NADH-cytochrome C reductase; inhibition of cell wall synthesis caused by D-alanine/D-alanine ligase inhibition; inhibition of cell membrane synthesis; and aggregation of bacterial cells. Furthermore, some studies suggest that flavonoids have multiple mechanisms of action [29, 48, 49].

This study showed that derriobtusone A inhibited biofilm formation, reducing the biomass and number of viable cells of Staphylococcus aureus (Figure 3) at concentrations of 250 and 500 μg/mL. Interestingly, although the planktonic growth of Escherichia coli was only weakly inhibited by derriobtusone A, the compound did reduce biomass in various concentrations and did weakly reduce the number of viable cells. Although several studies have reported on the antibacterial action of flavonoids, few works describe the potential antibiofilm activity of these molecules. A synthetic flavonoid, 3-arylideneflavanone 2C, showed antibacterial activity against Staphylococcus aureus and inhibited the initial adhesion of bacteria to abiotic surfaces, resulting in blocking biofilm formation [50]. Vikram and colleagues [46] showed that citrus flavonoids were able to reduce the biofilm formation of Vibrio harveyi and Escherichia coli. Using lectins, Liljemark and colleagues [51] showed that the formation of cellular aggregates decreased the number of adherent streptococci and, consequently, biofilm formation. Flavonoids have the ability to aggregate bacterial cells, thereby potentially explaining the antibiofilm activity of derriobtusone A [29]. Furthermore, an apple flavonoid, phloretin, inhibits suppressed autoinducer-2 importer genes (lsrACDBF) of Escherichia coli, suggesting that this compound interferes with bacterial quorum-sensing (AI-2) signaling. This study also showed that phloretin reduces fimbria production of Escherichia coli [52]. Fimbriae are important structures that influence bacterial adhesion. Thus, the inhibition of fimbria formation could be a way to decrease biofilm formation [52, 53].

In addition, derriobtusone A showed potential antioxidant activity (Figure 4). Plant phenolic compounds, such flavonoids, have been associated with the health benefits derived from consuming high levels of fruits and vegetables, and these effects have been attributed to their antioxidant activity [54, 55]. According to Narsinghani and colleagues [56], aurone derivatives have displayed several pharmacological activities, including antioxidant activities, and changes in their structure have been important in the development of new antioxidant compounds with improved potency and less toxicity.

In the present study, derriobtusone A demonstrated its ability to scavenge DPPH radical. Even at the lowest concentration tested, the compound displayed over 50% DPPH activity and also showed moderate chelating ability of ferrous ion. These results corroborate those of Narsinghani and colleagues [56] who showed significant antioxidant activity for five synthetic aurones, using these same two methods; however, the synthetic compounds showed a satisfactory reducing power, a fact not evidenced in this study. Moreover, the compound showed a high potential for inhibiting β-carotene oxidation by protecting it against free radicals generated during linoleic acid peroxidation, in some concentrations with activity similar to that of BHA. It is interesting to note that both derriobtusone A and BHA are compounds that exhibit apolar characteristics. Furthermore, according to Frankel and Meyer [57], antioxidants with apolar properties are most important because they are concentrated in the lipid-water interface, thereby preventing the formation of lipid radicals and β-carotene oxidation. Another interesting observation is that BHA at high concentrations may induce gastrointestinal hyperplasia [58].

Studies have shown that the antioxidant activity of flavonoids depends on the arrangement of functional groups about the nuclear structure [54, 59]. Multiple hydroxyl groups and their position in the molecule confer upon the molecule substantial antioxidant, chelating, and prooxidant activity, while O-methylation can suppress the action of the compound [60, 61]. Other structural features important for the antioxidant activity of flavonoids are the presence of unsaturation in conjugation with a 4-oxo-function in the C-ring and the presence of functional groups capable of binding transition metal ions. The lack of these groups in derriobtusone A may explain the moderate chelating ability of ferrous ion and ferric-reducing power presented in this study [62].

The question of flavonoid toxicity has been raised, even though this compound is widely distributed in edible plants and beverages [28]. Despite the minimal toxicity in such plants and beverages, Magalhães and colleagues [40] showed that flavonoids from Lonchocarpus montanus displayed high toxicity in their brine shrimp lethality assay, including derriobtusone A (LD₅₀ − 1.6 μg/mL). Corroborating this result, Santos and colleagues [21] showed that the extract from the root bark of Lonchocarpus filipes and three flavonoids isolated from this plant displayed high toxicity using the same assay. Interestingly, derriobtusone A from Lonchocarpus obtusus was shown to be nontoxic to Artemia sp. nauplii in the present study.

In summary, derriobtusone A showed potential antibacterial activity against Staphylococcus aureus and the ability to inhibit its biofilm formation. A decrease of Escherichia coli biofilm biomass was also shown. Furthermore, the compound showed antioxidant potential without toxicity. Thus, derriobtusone A may be a potential agent against infections caused by Staphylococcus aureus biofilms, and it may also have antioxidant properties for possible use against oxidative stress.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This study was supported by CAPES (Brazil) through the BEX NT 2052/11NT3 Project and by IBB-CEB and FCT (Portugal) and European Community Fund FEDER, through Program COMPETE, in the ambit of Project PTDC/SAU-ESA/646091/2006/FCOMP-01-0124-FEDER-007480. Otília Deusdênia Loiola Pessoa, Benildo Sousa Cavada, and Edson Holanda Teixeira are Senior Fellows of CNPq. Mr. David Martin helped with the English editing of the paper.

References

W. M. Dunne Jr., “Bacterial adhesion: seen any good biofilms lately?” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 155–166, 2002.

I. B. Beech, J. A. Sunner, and K. Hiraoka, “Microbe-surface interactions in biofouling and biocorrosion processes,” International Microbiology, vol. 8, no. 3, pp. 157–168, 2005.

P. H. Mc Cay, A. A. Ocampo-Sosa, and G. T. A. Fleming, “Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture,” Microbiology, vol. 156, no. 1, pp. 30–38, 2010.

M. R. Hall, E. McGillicuddy, and L. J. Kaplan, “Biofilm: basic principles, pathophysiology, and implications for clinicians,” Surgical Infections, vol. 15, no. 1, pp. 1–7, 2014.

C. N. Murphy and S. Clegg, “Klebsiella pneumoniae and type 3 fimbriae: nosocomial infection, regulation and biofilm formation,” Future Microbiology, vol. 7, no. 8, pp. 991–1002, 2012.

J. L. Brooks and K. K. Jefferson, “Staphylococcal biofilms. Quest for the magic bullet,” Advances in Applied Microbiology, vol. 81, pp. 63–87, 2012.

F. Mika and R. Hengge, “Small regulatory RNAs in the control of motility and biofilm formation in E. coli and Salmonella,” International Journal of Molecular Sciences, vol. 14, no. 3, pp. 4560–4579, 2013.

A. Sher, “Antimicrobial activity of natural products from medicinal plants,” Gomal Journal of Medical Sciences, vol. 7, no. 1, pp. 72–78, 2009.

D. Savoia, “Plant-derived antimicrobial compounds: alternatives to antibiotics,” Future Microbiology, vol. 7, no. 8, pp. 979–990, 2012.

V. Kuete, “Potential of Cameroonian plants and derived products against microbial infections: a review,” Planta Medica, vol. 76, no. 14, pp. 1479–1491, 2010.

M. Artini, R. Papa, G. Barbato et al., “Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds,” Bioorganic and Medicinal Chemistry, vol. 20, no. 2, pp. 920–926, 2012.

L. Cobrado, M. M. Azevedo, A. Silva-Dias, J. P. Ramos, C. Pina-Vaz, and A. G. Rodrigues, “Cerium, chitosan and hamamelitannin as novel biofilm inhibitors?” Journal of Antimicrobial Chemotherapy, vol. 67, no. 5, pp. 1159–1162, 2012.

I. Hernández, L. Alegre, F. van Breusegem, and S. Munné-Bosch, “How relevant are flavonoids as antioxidants in plants?” Trends in Plant Science, vol. 14, no. 3, pp. 125–132, 2009.

K. Asada, “Production and scavenging of reactive oxygen species in chloroplasts and their functions,” Plant Physiology, vol. 141, no. 2, pp. 391–396, 2006.

F. van Breusegem and J. F. Dat, “Reactive oxygen species in plant cell death,” Plant Physiology, vol. 141, no. 2, pp. 384–390, 2006.

K. Brieger, S. Schiavone, F. J. Miller Jr., and K. Krause, “Reactive oxygen species: from health to disease,” Swiss Medical Weekly, vol. 142, Article ID w13659, 2012.

S. A. Stanner, J. Hughes, C. N. M. Kelly, and J. Buttriss, “A review of the epidemiological evidence for the ‘antioxidant hypothesis’,” Public Health Nutrition, vol. 7, no. 3, pp. 407–422, 2004.

P. G. Waterman and E. N. Mahmoud, “Flavonoids from the seeds of Lonchocarpus costaricensis,” Phytochemistry, vol. 24, no. 3, pp. 571–574, 1985.

A. F. Magalhães, C. C. Santos, E. G. Magalhães, and M. A. Nogueira, “Detection of polyhydroxyalkaloids in Lonchocarpus extracts by GC-MS of acetylated derivatives,” Phytochemical Analysis, vol. 13, no. 4, pp. 215–221, 2002.

M. C. Nascimento, R. L. V. Dias, and W. B. Mors, “Flavonoids of Derris obtusa: aurones and auronols,” Phytochemistry, vol. 15, no. 10, pp. 1553–1558, 1976.

E. L. Santos, E. V. Costa, F. A. Marques et al., “Toxicity and antioxidant activity of flavonoids from Lonchocarpus filipes root bark,” Quimica Nova, vol. 32, no. 9, pp. 2255–2258, 2009.

M. G. B. Cavalcante, R. M. Silva, P. N. Bandeira et al., “Furanoflavones and other chemical constituents of Lonchocarpus obtusos,” Journal of the Brazilian Chemical Society, vol. 23, no. 2, pp. 301–305, 2012.

J. P. Brown, “A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds,” Mutation Research, vol. 75, no. 3, pp. 243–277, 1980.

M. H. Pan, C. S. Lai, and C. T. Ho, “Anti-inflammatory activity of natural dietary flavonoids,” Food and Function, vol. 1, no. 1, pp. 15–31, 2010.

M. Kawai, T. Hirano, S. Higa et al., “Flavonoids and related compounds as anti-allergic substances,” Allergology International, vol. 56, no. 2, pp. 113–123, 2007.

N. Masuoka, M. Matsuda, and I. Kubo, “Characterisation of the antioxidant activity of flavonoids,” Food Chemistry, vol. 131, no. 2, pp. 541–545, 2012.

W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang, “Flavonoids: promising anticancer agents,” Medicinal Research Reviews, vol. 23, no. 4, pp. 519–534, 2003.

T. P. T. Cushnie and A. J. Lamb, “Antimicrobial activity of flavonoids,” International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 343–356, 2005.

T. P. T. Cushnie and A. J. Lamb, “Recent advances in understanding the antibacterial properties of flavonoids,” International Journal of Antimicrobial Agents, vol. 38, no. 2, pp. 99–107, 2011.

M. Roussaki, S. C. Lima, A. Kypreou, P. Kefalas, A. C. Silva, and A. Detsi, “Aurones: a promising heterocyclic scaffold for the development of potent antileishmanial agents,” International Journal of Medicinal Chemistry, vol. 2012, Article ID 196921, 8 pages, 2012.

T. Iwashina, “The structure and distribution of the flavonoids in plants,” Journal of Plant Research, vol. 113, no. 1111, pp. 287–299, 2000.

R. Haudecoeur and A. Boumendjel, “Recent advances in the medicinal chemistry of aurones,” Current Medicinal Chemistry, vol. 19, no. 18, pp. 2861–2875, 2012.

S. Stepanović, D. Vuković, I. Dakić, B. Savić, and M. Švabić-Vlahović, “A modified microtiter-plate test for quantification of staphylococcal biofilm formation,” Journal of Microbiological Methods, vol. 40, no. 2, pp. 175–179, 2000.

X. J. Duan, W. W. Zhang, X. M. Li, and B. G. Wang, “Evaluation of antioxidant property of extract and fractions obtained from a red alga, Polysiphonia urceolata,” Food Chemistry, vol. 95, no. 1, pp. 37–43, 2006.

T. Wang, R. Jónsdóttir, and G. Ólafsdóttir, “Total phenolic compounds, radical scavenging and metal chelation of extracts from Icelandic seaweeds,” Food Chemistry, vol. 116, no. 1, pp. 240–248, 2009.

P. Ganesan, C. S. Kumar, and N. Bhaskar, “Antioxidant properties of methanol extract and its solvent fractions obtained from selected Indian red seaweeds,” Bioresource Technology, vol. 99, no. 8, pp. 2717–2723, 2008.

Y. L. Chew, Y. Y. Lim, M. Omar, and K. S. Khoo, “Antioxidant activity of three edible seaweeds from two areas in South East Asia,” LWT—Food Science and Technology, vol. 41, no. 6, pp. 1067–1072, 2008.

M. R. Parsek and P. K. Singh, “Bacterial biofilms: an emerging link to disease pathogenesis,” Annual Review of Microbiology, vol. 57, pp. 677–701, 2003.

F. M. Millezi, M. O. Pereira, N. N. Batista et al., “Susceptibility of monospecies and dual-species biofilms of Staphylococcus aureus and Escherichia coli to essential oils,” Journal of Food Safety, vol. 32, no. 3, pp. 351–359, 2012.

D. F. Magalhães, A. M. G. A. Tozzi, E. G. Magalhães, M. Sannomiya, A. D. P. C. Soriano, and M. A. F. Perez, “Flavonoids of Lonchocarpus montanus A.M.G. Azevedo and biological activity,” Annals of the Brazilian Academy of Sciences, vol. 79, no. 3, pp. 351–367, 2007.

Y. Rukayadi, K. Lee, S. Han, D. Yong, and J. K. Hwang, “In vitro activities of panduratin A against clinical Staphylococcus strains,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 10, pp. 4529–4532, 2009.

M. M. Radwan, R. Rodriguez-Guzman, S. P. Manly, M. Jacob, and S. A. Ross, “Sepicanin A—a new geranyl flavanone from Artocarpus sepicanus with activity against methicillin-resistant Staphylococcus aureus (MRSA),” Phytochemistry Letters, vol. 2, no. 4, pp. 141–143, 2009.

L. E. Alcaraz, S. E. Blanco, O. N. Puig, F. Tomas, and F. H. Ferretti, “Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains,” Journal of Theoretical Biology, vol. 205, no. 2, pp. 231–240, 2000.

A. Basile, S. Sorbo, S. Giordano et al., “Antibacterial and allelopathic activity of extract from Castanea sativa leaves,” Fitoterapia, vol. 71, supplement 1, pp. S110–S116, 2000.

Y. Sato, S. Suzaki, T. Tishikawa, M. Kihara, H. Shibata, and T. Higuti, “Phytochemical flavones isolated from Scutellaria barbata and antibacterial activity against methicillin-resistant Staphylococcus aureus,” Journal of Ethnopharmacology, vol. 72, no. 3, pp. 483–488, 2000.

A. Vikram, G. K. Jayaprakasha, P. R. Jesudhasan, S. D. Pillai, and B. S. Patil, “Suppression of bacterial cell-cell signalling, biofilm formation and type III secretion system by citrus flavonoids,” Journal of Applied Microbiology, vol. 109, no. 2, pp. 515–527, 2010.

H. Q. Li, L. Shi, Q. S. Li et al., “Synthesis of C(7) modified chrysin derivatives designing to inhibit β-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics,” Bioorganic and Medicinal Chemistry, vol. 17, no. 17, pp. 6264–6269, 2009.

N. C. Gordon and D. W. Wareham, “Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia,” International Journal of Antimicrobial Agents, vol. 36, no. 2, pp. 129–131, 2010.

D. Wu, Y. Kong, C. Han et al., “D-alanine:D-alanine ligase as a new target for the flavonoids quercetin and apigenin,” International Journal of Antimicrobial Agents, vol. 32, no. 5, pp. 421–426, 2008.

A. Budzyńska, M. Rózalski, W. Karolczak, M. Wieckowska-Szakiel, B. Sadowska, and B. Rózalska, “Synthetic 3-arylideneflavanones as inhibitors of the initial stages of biofilm formation by Staphylococcus aureus and Enterococcus faecalis,” Zeitschrift für Naturforschung C: Journal of Biosciences, vol. 66, no. 3-4, pp. 104–114, 2011.

W. F. Liljemark, C. G. Bloomquist, and G. R. Germaine, “Effect of bacterial aggregation on the adherence of oral streptococci to hydroxyapatite,” Infection and Immunity, vol. 31, no. 3, pp. 935–941, 1981.

J. H. Lee, S. C. Regmi, J. A. Kim et al., “Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats,” Infection and Immunity, vol. 79, no. 12, pp. 4819–4827, 2011.

M. A. Rendón, Z. Saldaña, A. L. Erdem et al., “Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 25, pp. 10637–10642, 2007.

K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, “Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships,” Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572–584, 2002.

N. Balasundram, K. Sundram, and S. Samman, “Phenolic compounds in plants and agri-industrial by-products: antioxidant activity, occurrence, and potential uses,” Food Chemistry, vol. 99, no. 1, pp. 191–203, 2006.

T. Narsinghani, M. C. Sharma, and S. Bhargav, “Synthesis, docking studies and antioxidant activity of some chalcone and aurone derivatives,” Medicinal Chemistry Research, vol. 22, no. 9, pp. 4059–4068, 2013.

E. N. Frankel and A. S. Meyer, “The problems of using one-dimensional methods to evaluate multifunctional food and biological antioxidants,” Journal of the Science of Food and Agriculture, vol. 80, no. 13, pp. 1925–1940, 2000.

C. Cruces-Blanco, A. S. Carretero, E. M. Boyle, and A. F. Gutiérrez, “The use of dansyl chloride in the spectrofluorimetric determination of the synthetic antioxidant butylated hydroxyanisole in foodstuffs,” Talanta, vol. 50, no. 5, pp. 1099–1108, 1999.

O. Farkas, J. Jakus, and K. Héberger, “Quantitative structure—antioxidant activity relationships of flavonoid compounds,” Molecules, vol. 9, no. 12, pp. 1079–1088, 2004.

G. Cao, E. Sofic, and R. L. Prior, “Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships,” Free Radical Biology and Medicine, vol. 22, no. 5, pp. 749–760, 1997.

S. Burda and W. Oleszek, “Antioxidant and antiradical activities of flavonoids,” Journal of Agricultural and Food Chemistry, vol. 49, no. 6, pp. 2774–2779, 2001.

C. A. Rice-Evans, N. J. Miller, and G. Paganga, “Structure-antioxidant activity relationships of flavonoids and phenolic acids,” Free Radical Biology and Medicine, vol. 20, no. 7, pp. 933–956, 1996.